FDA Notifications: New labeling for N-9 products?
FDA Notifications: New labeling for N-9 products?
Based on the results of several clinical trials, the Food and Drug Administration (FDA) has proposed new labeling for over-the-counter vaginal contraceptive drug products that contain nonoxynol 9 (N-9). The warning statements will tell consumers that vaginal contraceptives containing N-9 do not protect against HIV or other sexually transmitted diseases. The trials showed that frequent use of N-9 products raise the risk of infection through increased vaginal irritation. The FDA will seek public input on the proposed statement as part of its ongoing review of over-the-counter drug products.
Based on the results of several clinical trials, the Food and Drug Administration (FDA) has proposed new labeling for over-the-counter vaginal contraceptive drug products that contain nonoxynol 9 (N-9).Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.